Adaptive Biotechnologies CorporationADPTNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
5.16
↓ 89% below average
Average (7y)
46.36
Historical baseline
Range
High:122.90
Low:4.35
CAGR
-36.4%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 5.16 | +18.6% |
| 2023 | 4.35 | -27.1% |
| 2022 | 5.97 | -76.4% |
| 2021 | 25.34 | -67.8% |
| 2020 | 78.71 | +82.9% |
| 2019 | 43.03 | -49.6% |
| 2018 | 85.43 | -30.5% |
| 2017 | 122.90 | - |